Some recent news on the Acticor Biotech team, a company dedicated to the development of an innovative, safe and effective treatment of ischemic stroke:<br>
• Acticor is currently selecting its main lead to enter the development phase.<br>
• Dr Gilles Avenard is the new President of the company.
